July 14, 2026: Park Medi World Ltd. (PARKHOSP) continues to strengthen its position in North India’s healthcare sector through a combination of greenfield expansion, strategic acquisitions and a cluster-based operating model. Following a management interaction and facility visit, Choice Institutional Equities has maintained its ‘BUY’ recommendation on the stock with a target price of ₹350, implying an upside of around 20.6% from the current market price of ₹290.
Author: Aadarsh Patel | EQMint
The brokerage believes the company’s disciplined expansion strategy, improving operational efficiencies and strong execution pipeline position it well for sustained growth over the coming years.
Aggressive Capacity Expansion Underway
One of the key highlights from the management interaction is the addition of Park Hospital Platinum, a 100-bed facility located adjacent to the existing 225-bed Palam Vihar Hospital in Gurugram.
The new hospital is expected to become operational by November 2026 with an estimated capital expenditure of ₹25 crore. The expansion is intended to ease pressure on the existing Palam Vihar hospital, which operated at around 86% occupancy in FY26, reflecting robust demand in the Gurugram market.
Following the commissioning of the new facility, Park Medi World’s consolidated capacity in Gurugram will increase to 750 beds, strengthening its presence in one of North India’s most competitive healthcare markets.
Entry into Uttarakhand Through Medicity Acquisition
The company has also entered Uttarakhand by acquiring the 330-bed Medicity Hospital in Rudrapur for ₹1.77 billion.
Management expects all 330 beds to become operational immediately after launch, enabling faster revenue generation. For the first year, the company is targeting:
- Revenue of approximately ₹100 crore
- EBITDA margin of around 20%
- PAT margin of nearly 12%
These metrics are expected to improve further in the second year through higher occupancy, better average revenue per occupied bed (ARPOB) and a richer mix of super-speciality services.
Cluster Model Driving Operational Efficiency
A key differentiator for Park Medi World remains its cluster-based operating model, where hospitals within a region share specialist doctors, advanced medical equipment and operational resources.
According to the management, this strategy improves:
- Doctor availability
- Asset utilization
- Procurement efficiencies
- Recruitment
- Overall operating margins
The company also benefits from 100% ownership of its hospital assets and relatively low capital expenditure of ₹34–35 lakh per bed, supporting affordable tertiary and quaternary healthcare delivery while maintaining healthy profitability.
Long-Term Growth Vision
Park Medi World expects its total bed capacity to reach approximately 5,590 beds by March 2028, driven by ongoing expansion projects and acquisitions. Over the longer term, management has reiterated its aspiration of building a 10,000-bed hospital network by FY33.
The company continues to evaluate acquisition opportunities in underpenetrated healthcare markets where infrastructure gaps and attractive valuations offer long-term growth potential.
Financial Outlook Remains Strong
Choice Institutional Equities projects robust financial growth over FY26–FY29:
- Revenue CAGR of 32.9%
- PAT CAGR of 39.2%
- EBITDA margins sustained at around 26.5%
- Improving ROCE from 19.5% in FY26 to 25.4% by FY29E
The brokerage also expects government receivable days to improve to below 100 days, supporting stronger working capital management.
Choice Maintains BUY Rating
Based on its management interaction and facility visit, Choice Institutional Equities has retained its BUY recommendation and values the company at 18x FY28E EV/EBITDA, resulting in a target price of ₹350.
EQMint Analysis on Park Medi World
Park Medi World continues to execute an expansion strategy focused on capacity addition, strategic acquisitions and operational efficiency. The company’s cluster-based healthcare model, combined with strong occupancy levels and disciplined capital allocation, provides visibility on future growth.
While hospital expansion requires sustained execution and capital deployment, the company’s plans to significantly increase bed capacity and improve profitability could strengthen its competitive position in North India’s healthcare market. Investors will closely monitor the successful commissioning of new hospitals, integration of acquired assets and the pace of occupancy growth over the coming quarters.
FAQ
Why has Choice Institutional Equities maintained a BUY rating on Park Medi World?
The brokerage cited the company’s expansion strategy, improving operational efficiency, strong earnings outlook and long-term growth potential, while maintaining a target price of ₹350.
What is Park Hospital Platinum?
It is a new 100-bed hospital being developed adjacent to the existing Palam Vihar facility in Gurugram and is expected to become operational by November 2026.
What acquisition has the company recently completed?
Park Medi World has acquired the 330-bed Medicity Hospital in Rudrapur, Uttarakhand for ₹1.77 billion.
What is the company’s long-term capacity target?
Management aims to expand its network to 10,000 beds by FY33.
What target price has Choice assigned to the stock?
Choice Institutional Equities has maintained a BUY rating with a target price of ₹350.
Fmore such information visit EQMint
Join our Whatsapp channel for timely updates: Whatsapp
Disclaimer: This article is not an investment advice and is for educational purpose only.
